tiprankstipranks
Ampio Pharmaceuticals Ends Equity Distribution and Alters Strategy
Company Announcements

Ampio Pharmaceuticals Ends Equity Distribution and Alters Strategy

Don't Miss our Black Friday Offers:

An announcement from Ampio Pharmaceuticals (AMPE) is now available.

Ampio Pharmaceuticals, Inc. has announced the termination of its at-the-market equity distribution agreement with H.C. Wainwright & Co., LLC, effective March 6, 2024. This agreement, initiated on September 18, 2023, was for the periodic sale of the company’s common stock. Following the termination, Ampio Pharmaceuticals has also filed to withdraw any unsold or unissued securities under its current registration, signaling a significant shift in its stock offering strategy.

See more insights into AMPE stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyBiotech Alert: Searches spiking for these stocks today
TheFlyAmpio announces NYSE delisting, SEC deregistration
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App